Phillips Courtney
General Counsel, Atreca, Inc.
Companies
- Maze Therapeutics, Inc.GC and Corp. Secretary Jan 30, 2025 to now1
- Atreca, Inc.General counsel Jul 17, 2019 to Apr 3, 20242
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Maze Therapeutics, Inc. MAZE7,007 shares3$212.8K at $30.36Sep 3, 2026
- Atreca, Inc.50,431 shares4Sep 1, 2023
As of each latest filing. The line shows shares held over time.
Recent filings
- Sep 3, 2026Sold 22 shares at $25.78 of Maze Therapeutics, Inc.3
- Sep 3, 2026Sold 1,990 shares at $26.01 of Maze Therapeutics, Inc.3
- Sep 2, 2026Sold 243 shares at $27.12 of Maze Therapeutics, Inc.3
- Sep 2, 2026Sold 1,738 shares at $26.38 of Maze Therapeutics, Inc.3
- Sep 1, 2026Exercised options 11,000 shares of Maze Therapeutics, Inc.5
- Sep 1, 2023Sold 7,061 shares at $0.37 of Atreca, Inc.4
- Aug 2, 2023Sold 4,076 shares at $0.95 of Atreca, Inc.6
- Feb 9, 2023Granted 32,500 shares of Atreca, Inc.7
- Sep 2, 2022Sold 6,432 shares at $1.78 of Atreca, Inc.8
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2SEC EDGARAtreca, Inc., General counsel
- 3
- 4
- 5SEC EDGARForm 4 filed Sep 3, 2026
- 6SEC EDGARForm 4 filed Aug 4, 2023
- 7SEC EDGARForm 4 filed Feb 13, 2023
- 8SEC EDGARForm 4 filed Sep 20, 2022